10x Genomics Return on Tangible Equity 2018-2025 | TXG
Current and historical return on tangible equity values for 10x Genomics (TXG) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| 10x Genomics Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.16B | $0.69B | -22.57% |
| 2024-12-31 | $-0.18B | $0.69B | -26.21% |
| 2024-09-30 | $-0.18B | $0.70B | -25.93% |
| 2024-06-30 | $-0.24B | $0.70B | -33.80% |
| 2024-03-31 | $-0.26B | $0.70B | -36.36% |
| 2023-12-31 | $-0.26B | $0.72B | -34.22% |
| 2023-09-30 | $-0.22B | $0.72B | -29.35% |
| 2023-06-30 | $-0.17B | $0.77B | -22.43% |
| 2023-03-31 | $-0.17B | $0.78B | -22.77% |
| 2022-12-31 | $-0.17B | $0.78B | -21.58% |
| 2022-09-30 | $-0.17B | $0.75B | -21.64% |
| 2022-06-30 | $-0.14B | $0.76B | -18.10% |
| 2022-03-31 | $-0.09B | $0.78B | -11.21% |
| 2021-12-31 | $-0.06B | $0.79B | -7.46% |
| 2021-09-30 | $-0.46B | $0.80B | -59.98% |
| 2021-06-30 | $-0.51B | $0.78B | -65.80% |
| 2021-03-31 | $-0.53B | $0.75B | -79.67% |
| 2020-12-31 | $-0.54B | $0.72B | -92.74% |
| 2020-09-30 | $-0.13B | $0.83B | -26.21% |
| 2020-06-30 | $-0.08B | $0.39B | -25.57% |
| 2020-03-31 | $-0.05B | $0.41B | -23.64% |
| 2019-12-31 | $-0.03B | $0.42B | -30.48% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.100B | $0.611B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.988B | 53.85 |
| Hims & Hers Health (HIMS) | United States | $13.954B | 144.98 |
| Tempus AI (TEM) | United States | $10.977B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.526B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.418B | 69.02 |
| Privia Health (PRVA) | United States | $3.048B | 208.33 |
| Enovis (ENOV) | United States | $2.027B | 11.30 |
| Clover Health Investments (CLOV) | United States | $1.832B | 0.00 |
| Schrodinger (SDGR) | United States | $1.721B | 0.00 |
| Phreesia (PHR) | United States | $1.510B | 0.00 |
| Omnicell (OMCL) | United States | $1.305B | 23.02 |
| Azenta (AZTA) | United States | $1.242B | 57.70 |
| Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.574B | 0.00 |
| Talkspace (TALK) | United States | $0.504B | 150.50 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Claritev (CTEV) | United States | $0.452B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.376B | 834.00 |
| Health Catalyst (HCAT) | United States | $0.271B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.231B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.134B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
| CareCloud (CCLD) | United States | $0.088B | 3.34 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |